| DOI: 10.29090/psa.2020.02.020.0026 | Pharm Sci Asia 2020; 47(2), 97-103 |
Pharmacological treatment for the Novel Coronavirus Disease 2019 (COVID-19 Infection)Nattapong Tidwong1, 2*, Preecha Montakantikul2, Weerawat Manosuthi3
1 Faculty of Pharmacy, Chiang Mai University, Chiang Mai, Thailand
2 Faculty of Pharmacy, Mahidol University, Bangkok, Thailand
3 Bamrasnaradura Infectious Diseases Institute, Nonthaburi, Thailand
As of March 22, 2020, a total of 292,142 confirmed coronavirus disease 2019 (COVID-19) cases have been reported globally. Although there are currently no specific antiviral agents but all coronaviruses shared similar key elements of target for currently approved antiviral or new drug development. Several agents might be considered as a possible treatment based on the efficacy in SARS and MERS.
Keyword:
Novel coronavirus; COVID-19; SARS-CoV-2; Antivirals
Download full paper (PDF File size: 350.18 KB.)
|
